The Political Economy Research Institute at the University of Massachusetts found that EPA's Clean Air Act cross-State air pollution rule and the mercury rule would together create nearly 1.5 million jobs over 5 years.
Henry Waxman
The Public Record
Henry Waxman is a former U.S. Representative from California, serving from 1975 to 2015. A member of the Democratic Party, he was known for his work on health care, environmental policy, and consumer protection. During his tenure, Waxman played a key role in the passage of the Affordable Care Act and was a prominent advocate for climate change legislation. He chaired the House Energy and Commerce Committee, where he focused on issues such as tobacco regulation and health care reform.
According to the EPA, the regulations that are subject to today's hearings will create 46,000 short-term construction jobs.
Clearly, this a Republican majority that has run out of new bad ideas, so they have just decided to recycle all of their old bad ideas.
We should be standing up for the health of infants and children, not the powerful coal and utility industries.
These new standards will cut emissions of toxic mercury by 90 percent. This is a major step forward.
Excuse me, you are going to have to use your regulatory authority to do something that should have been said in the law by Congress.
The report calls into question the adequacy of the program's performance standards.
None of us can be happy about this memo that came out last November, showing how poorly this program is serving the American public.
We didn't do our job, and that legislation needs to be revisited in light of this new information.
The challenges described in the memo are serious, and they must be addressed.
It is stunning to realize that this committee of Congress... reported legislation that simply rubber-stamped the current program for 7 additional years.
This program is intended to address the threat of terrorism to the Nation's chemical facilities.
Well, we all want these drugs on the market as fast as possible but I would be concerned about any proposal to remove FDA's ability to require clinical data when FDA thinks it is essential to assure that these drugs are safe and effective…
I agree, it is critical to retain that sunset provision so we have an opportunity to evaluate these questions, both the balance and the research questions as well.
I want to thank Representatives Mike Rogers and Anna Eshoo, who are leading the reauthorization efforts on these important laws.
Above all else, we must ensure that the prescriptions our children use are tested appropriately and deemed safe.
I believe that Americans deserve the confidence that the drugs they rely on will help them get better and not make them more sick.
When we examine claims as serious as these, we must insist on data and on facts.
I hope we would all agree that FDA should not take jobs into consideration when it is reviewing the safety and effectiveness of a new medicine.
It would be irresponsible to allow this legislation to become a vehicle for the wish lists of members seeking to move their own controversial bills.
We must reauthorize and establish these essential programs in a timely way so that FDA can do its job protecting the health and safety of American patients.
The drug and device user fee programs ensure that FDA gets critical dollars to allow the agency to complete its premarket review in a timely manner.





